Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.94
-0.33 (-3.21%)
At close: Mar 9, 2026, 4:00 PM EDT
9.79
-0.15 (-1.51%)
After-hours: Mar 9, 2026, 7:39 PM EDT
Ocular Therapeutix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 737.06 | 392.1 | 195.81 | 102.3 | 164.16 | Upgrade
|
| Cash & Short-Term Investments | 737.06 | 392.1 | 195.81 | 102.3 | 164.16 | Upgrade
|
| Cash Growth | 87.98% | 100.25% | 91.41% | -37.68% | -28.02% | Upgrade
|
| Accounts Receivable | 30.65 | 32.39 | 26.18 | 21.33 | 21.14 | Upgrade
|
| Other Receivables | - | 0.18 | - | - | - | Upgrade
|
| Receivables | 30.65 | 32.56 | 26.18 | 21.33 | 21.14 | Upgrade
|
| Inventory | 3.56 | 3.04 | 2.31 | 1.97 | 1.25 | Upgrade
|
| Prepaid Expenses | 10.86 | 13.28 | 7.79 | 4.03 | 4.75 | Upgrade
|
| Restricted Cash | - | - | 0.15 | - | - | Upgrade
|
| Total Current Assets | 782.13 | 440.99 | 232.24 | 129.63 | 191.3 | Upgrade
|
| Property, Plant & Equipment | 24.31 | 15.33 | 18.21 | 17.9 | 11.82 | Upgrade
|
| Other Long-Term Assets | 1.61 | 1.61 | 1.61 | 1.76 | 1.76 | Upgrade
|
| Total Assets | 808.06 | 457.94 | 252.06 | 149.29 | 204.89 | Upgrade
|
| Accounts Payable | 4.15 | 4.18 | 4.39 | 5.12 | 4.59 | Upgrade
|
| Accrued Expenses | 43.84 | 35.12 | 28.67 | 24.1 | 20.12 | Upgrade
|
| Current Portion of Leases | 2.82 | 1.93 | 1.59 | 1.6 | 1.62 | Upgrade
|
| Current Unearned Revenue | - | 0.13 | 0.26 | 0.58 | - | Upgrade
|
| Total Current Liabilities | 50.81 | 41.35 | 34.9 | 31.4 | 26.34 | Upgrade
|
| Long-Term Debt | 71.34 | 68.51 | 74.93 | 54.01 | 51.44 | Upgrade
|
| Long-Term Leases | 2.82 | 5.35 | 6.88 | 8.68 | 5.92 | Upgrade
|
| Long-Term Unearned Revenue | 14 | 14 | 14.14 | 13.39 | 13 | Upgrade
|
| Other Long-Term Liabilities | 14.79 | 13.39 | 30.1 | 6.44 | 20.19 | Upgrade
|
| Total Liabilities | 153.75 | 142.59 | 160.93 | 113.91 | 116.89 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,811 | 1,206 | 788.7 | 652.21 | 633.8 | Upgrade
|
| Retained Earnings | -1,157 | -891.08 | -697.58 | -616.84 | -545.8 | Upgrade
|
| Shareholders' Equity | 654.31 | 315.34 | 91.13 | 35.38 | 88 | Upgrade
|
| Total Liabilities & Equity | 808.06 | 457.94 | 252.06 | 149.29 | 204.89 | Upgrade
|
| Total Debt | 76.97 | 75.78 | 83.39 | 64.28 | 58.98 | Upgrade
|
| Net Cash (Debt) | 660.09 | 316.32 | 112.42 | 38.02 | 105.18 | Upgrade
|
| Net Cash Growth | 108.68% | 181.38% | 195.70% | -63.86% | -37.99% | Upgrade
|
| Net Cash Per Share | 3.53 | 2.00 | 1.31 | 0.46 | 1.28 | Upgrade
|
| Filing Date Shares Outstanding | 217.69 | 159.02 | 148.63 | 77.51 | 76.75 | Upgrade
|
| Total Common Shares Outstanding | 215.93 | 157.75 | 114.96 | 77.2 | 76.73 | Upgrade
|
| Working Capital | 731.32 | 399.63 | 197.34 | 98.23 | 164.96 | Upgrade
|
| Book Value Per Share | 3.03 | 2.00 | 0.79 | 0.46 | 1.15 | Upgrade
|
| Tangible Book Value | 654.31 | 315.34 | 91.13 | 35.38 | 88 | Upgrade
|
| Tangible Book Value Per Share | 3.03 | 2.00 | 0.79 | 0.46 | 1.15 | Upgrade
|
| Machinery | 21.33 | 18.05 | 16.78 | 13.75 | 12.28 | Upgrade
|
| Construction In Progress | 10.26 | 0.12 | 0.28 | 4.07 | 0.58 | Upgrade
|
| Leasehold Improvements | 15.28 | 14.53 | 14.7 | 9.07 | 9.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.